Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant.

Warsame R, Bang SM, Kumar SK, Gertz MA, Lacy MQ, Buadi F, Dingli D, Hayman SR, Kapoor P, Kyle RA, Leung N, Lust JA, Russell SJ, Witzig TE, Zeldenrust SR, Rajkumar SV, Dispenzieri A.

Eur J Haematol. 2014 Jun;92(6):485-90. doi: 10.1111/ejh.12282. Epub 2014 Mar 2.

PMID:
24502602
[PubMed - in process]
2.

Autologous stem cell transplantation and IgM amyloidosis.

Valente M, Roy V, Lacy MQ, Dispenzieri A, Gertz MA.

Leuk Lymphoma. 2006 Jun;47(6):1006-12.

PMID:
16840189
[PubMed - indexed for MEDLINE]
3.

Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry.

Alegre A, Granda A, Martínez-Chamorro C, Díaz-Mediavilla J, Martínez R, García-Laraña J, Lahuerta JJ, Sureda A, Bladé J, de la Rubia J, Fernández-Rañada JM, San Miguel J; Spanish Registry of Transplants in Multiple Myelomas; Spanish Group of Hemopoietic Transplant (GETH); PETHEMA.

Haematologica. 2002 Jun;87(6):609-14.

PMID:
12031917
[PubMed - indexed for MEDLINE]
Free Article
4.

Bortezomib, melphalan, and prednisolone combination chemotherapy for newly diagnosed light chain (AL) amyloidosis.

Lee JY, Lim SH, Kim SJ, Lee GY, Lee JE, Choi JO, Kim JS, Kim HJ, Lee SY, Min JH, Jeon ES, Kim K.

Amyloid. 2014 Dec;21(4):261-6. doi: 10.3109/13506129.2014.960560. Epub 2014 Sep 24.

PMID:
25248716
[PubMed - in process]
5.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
[PubMed - indexed for MEDLINE]
6.

Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report.

Gertz MA, Lacy MQ, Dispenzieri A, Hayman SR, Kumar SK, Dingli D, Ansell SM, Gastineau DA, Inwards DJ, Johnston PB, Litzow MR, Micallef IN, Porrata LF, Leung N, Hogan WJ, Buadi FK.

Leuk Lymphoma. 2010 Dec;51(12):2181-7. doi: 10.3109/10428194.2010.524329. Epub 2010 Oct 20.

PMID:
20958232
[PubMed - indexed for MEDLINE]
7.

Systemic light-chain amyloidosis: advances in diagnosis, prognosis, and therapy.

Cohen AD, Comenzo RL.

Hematology Am Soc Hematol Educ Program. 2010;2010:287-94. doi: 10.1182/asheducation-2010.1.287. Review.

PMID:
21239808
[PubMed - indexed for MEDLINE]
Free Article
8.

Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation.

Herrmann SM, Gertz MA, Stegall MD, Dispenzieri A, Cosio FC, Kumar S, Lacy MQ, Dean PG, Prieto M, Zeldenrust SR, Buadi FK, Russell SJ, Nyberg SL, Hayman SR, Dingli D, Fervenza FC, Leung N.

Nephrol Dial Transplant. 2011 Jun;26(6):2032-6. doi: 10.1093/ndt/gfr067. Epub 2011 May 4.

PMID:
21543655
[PubMed - indexed for MEDLINE]
Free Article
9.

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).

Lazarus HM, Loberiza FR Jr, Zhang MJ, Armitage JO, Ballen KK, Bashey A, Bolwell BJ, Burns LJ, Freytes CO, Gale RP, Gibson J, Herzig RH, LeMaistre CF, Marks D, Mason J, Miller AM, Milone GA, Pavlovsky S, Reece DE, Rizzo JD, van Besien K, Vose JM, Horowitz MM.

Bone Marrow Transplant. 2001 Feb;27(4):387-96.

PMID:
11313668
[PubMed - indexed for MEDLINE]
Free Article
10.

Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.

Lacy MQ, Dispenzieri A, Hayman SR, Kumar S, Kyle RA, Rajkumar SV, Edwards BS, Rodeheffer RJ, Frantz RP, Kushwaha SS, Clavell AL, Dearani JA, Sundt TM, Daly RC, McGregor CG, Gastineau DA, Litzow MR, Gertz MA.

J Heart Lung Transplant. 2008 Aug;27(8):823-9. doi: 10.1016/j.healun.2008.05.016. Epub 2008 Jul 3.

PMID:
18656793
[PubMed - indexed for MEDLINE]
11.

Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.

Brice P, Bouabdallah R, Moreau P, Divine M, André M, Aoudjane M, Fleury J, Anglaret B, Baruchel A, Sensebe L, Colombat P.

Bone Marrow Transplant. 1997 Jul;20(1):21-6.

PMID:
9232251
[PubMed - indexed for MEDLINE]
Free Article
12.

[Treatment of AL-amyloidosis--results from one clinic and review of published experience with new agents (bortezomib, thalidomide and lenalidomide) in AL-amyloidosis].

Adam Z, Pour L, Krejcí M, Zahradová L, Krivanová A, Mardová J, Kovárová L, Stepánková S, Moulis M, Kren L, Veselý K, Svobodová I, Germáková Z, Nedbálková M, Mayer J, Hájek R.

Vnitr Lek. 2010 Mar;56(3):190-209. Review. Czech.

PMID:
20394205
[PubMed - indexed for MEDLINE]
13.

[Heart transplantation and the subsequent treatment of AL amyloidosis].

Adam Z, Krejčí J, Krejčí M, Němec P, Spinarová L, Zampachová V, Cermáková Z, Pika T, Pour L, Kořístek Z, Tomíška M, Szturz P, Král Z, Mayer J.

Vnitr Lek. 2013 Feb;59(2):136-47. Czech.

PMID:
23461404
[PubMed - indexed for MEDLINE]
14.

Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma.

Nademanee A, Molina A, Dagis A, Snyder DS, O'Donnell MR, Parker P, Stein A, Smith E, Planas I, Kashyap A, Spielberger R, Fung H, Krishnan A, Bhatia R, Wong KK, Somlo G, Margolin K, Chow W, Sniecinski I, Vora N, Slovak M, Niland JC, Forman SJ.

Clin Lymphoma. 2000 Jun;1(1):46-54.

PMID:
11707813
[PubMed - indexed for MEDLINE]
15.

High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer.

Demirer T, Buckner CD, Appelbaum FR, Clift R, Storb R, Myerson D, Lilleby K, Rowley S, Bensinger WI.

Bone Marrow Transplant. 1996 May;17(5):769-74.

PMID:
8733696
[PubMed - indexed for MEDLINE]
16.

Dose intensification with autologous stem cell transplantation in relapsed and resistant Hodgkin's disease.

Anselmo AP, Cavalieri E, Meloni G, Alimena G, Cantonetti M, Maurizi Enrici R, Tosti ME, Falchetto Osti M, Gianfelici V, Mandelli F.

Haematologica. 2002 May;87(5):507-11.

PMID:
12010664
[PubMed - indexed for MEDLINE]
Free Article
17.

Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis.

Comenzo RL.

Contrib Nephrol. 2007;153:195-210. Review.

PMID:
17075231
[PubMed - indexed for MEDLINE]
19.
20.

[Treatment of AL amyloidosis in 2012; the benefit of new drugs (bortezomib, thalidomide, and lenalidomide). Summary of published clinical trials].

Adam Z, Sčudla V, Krejčí M, Cermáková Z, Pour L, Král Z.

Vnitr Lek. 2013 Jan;59(1):37-58. Review. Czech.

PMID:
23428001
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk